Levi Strauss & Co. (LEVI) Q3 2026: Leadership Transition Amid Growth Ambitions — Positive Outlook
QuoteReporter
Levi Strauss & Co. (LS&Co.) has announced a significant leadership change with the appointment of John Vandemore as Chief Financial Officer, effective November 1, 2026. This transition comes at a pivotal moment for the company as it aims to enhance its direct-to-consumer business and achieve its goal of becoming a $10 billion company. While the filing does not provide specific quarterly financial results, the strategic direction and leadership experience of Vandemore suggest a positive outlook for shareholders.
Key Highlights:
- New CFO Appointment: John Vandemore, with over 25 years of experience in finance leadership across consumer-facing industries, will take over as CFO.
- Previous Success: Vandemore previously served as CFO at Skechers U.S.A., where he helped grow revenues to over $9 billion.
- Company Vision: The leadership emphasizes a strategy focused on unlocking the full potential of the Levi’s® brand and transforming LS&Co. into a leading denim lifestyle retailer.
- Transition Period: Harmit Singh, the outgoing CFO, will remain as a Special Advisor until November 30, 2026, to ensure a smooth transition.
Analyst View:
This quarter appears to be a strategic pivot rather than a traditional earnings report, focusing on leadership that aligns with LS&Co.'s growth ambitions. The appointment of Vandemore is a positive signal for shareholders, as his extensive background in scaling brands and driving profitability could lead to enhanced financial performance. The company’s goal of reaching $10 billion in revenue indicates a strong growth trajectory, which could translate into increased shareholder value in the long term.
Forward Catalyst:
Investors should watch for updates on LS&Co.'s financial performance in the upcoming quarters, particularly how Vandemore's strategies will impact revenue growth and profitability. Additionally, any announcements regarding new product lines or market expansions could serve as key indicators of the company's progress toward its ambitious goals.
It appears that the press release provided does not include any financial tables such as an Income Statement or Balance Sheet. Therefore, I am unable to extract the requested tables since they are not present in the text provided. If you have a different document or can provide the specific sections that contain these tables, please share that information.
Quarterly Earnings — Revenue vs. Estimate
| Quarter Label | Quarter End | Rev Actual ($M) | Rev Est ($M) | Rev Var ($M) | EPS Actual | EPS Est | EPS Beat |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-10 | 1,610 | 1,620 | -10 | 0.48 | 0.36 | +0.12 |
| Q2 2026 | 2026-05-31 | 1,560 | 1,520 | +40 | 0.28 | 0.24 | +0.04 |
| Q1 2026 | 2026-02-28 | 1,740 | 1,650 | +90 | 0.42 | 0.37 | +0.05 |
| Q4 2025 | 2025-11-30 | 1,770 | 1,710 | +60 | 0.41 | 0.39 | +0.02 |
| Q3 2025 | 2025-08-31 | 1,540 | 1,500 | +40 | 0.34 | 0.31 | +0.03 |
Revenue vs. Estimate — 5 Quarters
EPS vs. Estimate — 5 Quarters
Analyst Ratings & Price Targets
| Date | Status | Outer | Rating | Price |
|---|---|---|---|---|
| 2026-07-28 | Downgrade | Wells Fargo | Overweight → Equal Weight | $25 |
| 2026-02-04 | Initiated | Jefferies | Buy | $25 |
| 2025-12-23 | Initiated | Raymond James | Outperform | $26 |
| 2025-10-15 | Initiated | BTIG Research | Buy | $27 |
| 2025-10-03 | Reiterated | Telsey Advisory Group | Outperform | $24 → $27 |
| 2025-09-25 | Initiated | Needham | Buy | $28 |
| 2025-07-11 | Reiterated | Telsey Advisory Group | Outperform | $21 → $24 |
| 2025-04-30 | Upgrade | Wells Fargo | Equal Weight → Overweight | $20 |
Wall Street analysts have shown mixed sentiment toward Levi Strauss & Co. (LEVI) in recent months. Wells Fargo downgraded the stock from Overweight to Equal Weight on July 28, 2026, setting a $25 price target, while Jefferies initiated coverage with a Buy rating at the same target in February. Earlier, Raymond James and BTIG Research initiated coverage with Outperform and Buy ratings, targeting $26 and $27, respectively. Telsey Advisory Group reiterated its Outperform rating in October 2025, raising its target from $24 to $27, and Needham initiated coverage with a Buy rating at $28. The consensus price target of approximately $26 suggests modest upside potential from LEVI's current trading levels, implying cautious optimism despite Wells Fargo’s more neutral stance. Recent analyst actions reflect a balance between upgrades, downgrades, and reiterated bullish calls.
Technical Analysis — 90-Day Price Chart
Levi Strauss & Co. (LEVI) trades at $19.51, below its short- and medium-term moving averages (SMA20: $19.9, SMA50: $21.37), signaling bearish pressure as both averages trend downward without recent bullish crossovers. The RSI(14) at 44.2 remains neutral, lacking momentum for a reversal. Volume surged to 17.46M shares vs. the 20-day average of 3.46M, suggesting heightened activity but unclear directional conviction. The stock hovers near its 52-week low ($19.16), with the high at $25.7, indicating weak upside momentum and potential support at the lower bound. A breach below $19.16 could intensify selling pressure, while resistance looms at the descending SMAs. The proximity to yearly lows underscores persistent bearish sentiment, requiring a sustained volume-backed rally to alter the downtrend.
